Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Softline received ₽1.55 billion on Belarus bonds

8/26/24 SOFL

Board of Directors of NovaBev Group recommended dividends

8/26/24 BELU

M.Video-Eldorado's GMV grew by 13% in the 1st half of the year

8/26/24 MVID

M.Video reported for 6 months of 2024 by IFRS

8/26/24 MVID

Element reported for 6 months of 2024 by IFRS

8/26/24 ELMT

Moscow Exchange reported for 6 months of 2024 by IFRS

8/26/24 MOEX

Moscow Exchange has developed a trading plan for the weekend

8/26/24 MOEX

Delimobil enters Perm

8/26/24 DELI

Abrau-Durso started production of sparkling drinks in India

8/26/24 ABRD

Russneft reported for 6 months of 2024 by IFRS

8/23/24 RNFT